SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

15 Jul 2025 Evaluate

Dr Reddys Laboratories has informed that it enclosed a press release titled ‘Dr. Reddy's to release Q1FY26 results on Wednesday, July 23rd, 2025; Earnings call slated for Wednesday, July 23rd @ 19:30 PM IST / 10:00 AM ET’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1223.90 -5.90 (-0.48%)
16-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1951.30
Dr. Reddys Labs. 1223.90
Cipla 1428.00
Lupin 2505.00
Zydus Lifesciences 1155.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: